About Matthew Rizzo
Form D filings for Evozyne in 2023 list Matthew Rizzo as director.
Matthew Rizzo first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Rizzo in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Rizzo works with at each company, as listed on that company's latest Form D.
Evozyne, Inc. · Form D, Sep 29, 2023
AG
Antonio Gracias
Director
JA
Jeffrey Aronin
Chairman and Director
AT
Aris Theologis
Chief Business Officer
DP
Darien Parhad
Chief Financial Officer and Treasurer
JS
Jude Sullivan
General Counsel and Secretary
AL
Aleina Lee
Corporate Controller
RR
Rama Ranganathan
Chief Scientific Officer and Director
PM
Patrick Morris
Executive officer and director
MG
Mike Gamson
President, Chief Executive Officer, and Director
AR
Arjun Rallapalli
Chief Operating Officer